| Browse All

Accuray Incorporated (ARAY)

Healthcare | Medical Devices | Madison, United States | NasdaqGS
0.45 USD -0.01 (-3.058%) ⇩ (April 21, 2026, 11:17 a.m. EDT)

Short-term: ☆☆☆☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆
Hot Take | April 18, 2026, 10:44 p.m. EDT

Despite a 'strong buy' analyst consensus driven by negative price action, the underlying fundamentals are dire with negative earnings, shrinking revenue, and massive debt relative to equity. The options market is screaming bearish, with traders buying protective puts while call volume is negligible. The forecasting model predicts a 26.6% drop. This stock is trapped in a death spiral with no catalyst for recovery; avoid entirely.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoARIMA ✓0.264654
AutoTheta0.323098
AutoETS0.530413
MSTL0.536291

Forecast horizon: 45 days | Selected: AutoARIMA

Forecast Reliability
Score 63%
H-stat 1.73
Ljung-Box p 0.000
Jarque-Bera p 0.377
Excess Kurtosis -0.44
Attribute Value
Sector Healthcare
Debt to Equity Ratio 326.144
Revenue per Share 3.889
Market Cap 53,464,064
Forward P/E -15.00
Beta 1.32
Profit Margins -8.15%
Website https://www.accuray.com

As of April 18, 2026, 10:44 p.m. EDT: Options sentiment is heavily skewed toward downside protection. While near-term calls show exceedingly low volume and open interest (single digits), puts in the June expiration exhibit significant positioning, particularly at the 1.0 strike (530 contracts) and 5.0 strike (outlier OI noted), suggesting strong plays against further declines or a high strike target. The implied volatility for the ATM put is significantly elevated (15.75% vs 4-5% for calls), indicating the market prices in a higher probability of a downward move for the short term. Speculators appear to be buying insurance or bearish calls rather than bullish momentum based on open interest distribution.


Info Dump

Attribute Value
52 Week Change -0.6973684
Address1 1,240 Deming Way
All Time High 31.09
All Time Low 0.33
Ask 0.5176
Ask Size 1
Audit Risk 10
Average Analyst Rating 1.0 - Strong Buy
Average Daily Volume10 Day 1,560,580
Average Daily Volume3 Month 1,312,463
Average Volume 1,312,463
Average Volume10Days 1,560,580
Beta 1.318
Bid 0.446
Bid Size 7
Board Risk 2
Book Value 0.45
City Madison
Compensation As Of Epoch Date 1,767,139,200
Compensation Risk 5
Country United States
Crypto Tradeable 0
Currency USD
Current Price 0.4501
Current Ratio 1.466
Custom Price Alert Confidence HIGH
Date Short Interest 1,774,915,200
Day High 0.4769
Day Low 0.446
Debt To Equity 326.144
Earnings Call Timestamp End 1,770,240,600
Earnings Call Timestamp Start 1,770,240,600
Earnings Timestamp 1,770,238,800
Earnings Timestamp End 1,777,492,800
Earnings Timestamp Start 1,777,492,800
Ebitda -1,700,000
Ebitda Margins -0.00389
Enterprise To Ebitda -110.636
Enterprise To Revenue 0.43
Enterprise Value 188,081,776
Eps Current Year -0.32
Eps Forward -0.03
Eps Trailing Twelve Months -0.31
Esg Populated 0
Exchange NMS
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fax 608 824 2996
Fifty Day Average 0.466
Fifty Day Average Change -0.015899986
Fifty Day Average Change Percent -0.034120142
Fifty Two Week Change Percent -69.73684
Fifty Two Week High 2.1
Fifty Two Week High Change -1.6499
Fifty Two Week High Change Percent -0.7856667
Fifty Two Week Low 0.33
Fifty Two Week Low Change 0.12009999
Fifty Two Week Low Change Percent 0.36393934
Fifty Two Week Range 0.33 - 2.1
Financial Currency USD
First Trade Date Milliseconds 1,170,945,000,000
Float Shares 112,937,337
Forward Eps -0.03
Forward P E -15.003334
Free Cashflow -803,500
Full Exchange Name NasdaqGS
Full Time Employees 990
Gmt Off Set Milliseconds -14,400,000
Governance Epoch Date 1,775,001,600
Gross Margins 0.27848
Gross Profits 121,689,000
Has Pre Post Market Data 1
Held Percent Insiders 0.040960003
Held Percent Institutions 0.70804
Implied Shares Outstanding 118,782,630
Industry Medical Devices
Industry Disp Medical Devices
Industry Key medical-devices
Ir Website http://investors.accuray.com/phoenix.zhtml?c=177244&p=irol-irhome
Is Earnings Date Estimate 1
Language en-US
Last Fiscal Year End 1,751,241,600
Long Business Summary Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. It also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, the company offers post-contract customer support, installation, training, and other professional services. It primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.
Long Name Accuray Incorporated
Market us_market
Market Cap 53,464,064
Market State REGULAR
Max Age 86,400
Message Board Id finmb_739115
Most Recent Quarter 1,767,139,200
Net Income To Common -35,622,000
Next Fiscal Year End 1,782,777,600
Non Diluted Market Cap 55,198,288
Number Of Analyst Opinions 2
Open 0.47
Operating Cashflow 4,547,000
Operating Margins -0.05371
Overall Risk 5
Payout Ratio 0.0
Peg Ratio 29.49
Phone 608 824 2800
Previous Close 0.4643
Price Eps Current Year -1.4065626
Price Hint 4
Price To Book 1.0002222
Price To Sales Trailing12 Months 0.12235208
Profit Margins -0.081520006
Quick Ratio 0.602
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key strong_buy
Recommendation Mean 1.0
Region US
Regular Market Change -0.014200002
Regular Market Change Percent -3.0583677
Regular Market Day High 0.4769
Regular Market Day Low 0.446
Regular Market Day Range 0.446 - 0.4769
Regular Market Open 0.47
Regular Market Previous Close 0.4643
Regular Market Price 0.4501
Regular Market Time 1,776,784,640
Regular Market Volume 330,797
Return On Assets -0.01176
Return On Equity -0.70322
Revenue Growth -0.12
Revenue Per Share 3.889
Sand P52 Week Change 0.34445214
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Share Holder Rights Risk 5
Shares Outstanding 118,782,630
Shares Percent Shares Out 0.064
Shares Short 7,606,209
Shares Short Previous Month Date 1,772,150,400
Shares Short Prior Month 5,471,116
Short Name Accuray Incorporated
Short Percent Of Float 0.0735
Short Ratio 5.0
Source Interval 15
State WI
Symbol ARAY
Target High Price 3.05
Target Low Price 2.0
Target Mean Price 2.525
Target Median Price 2.525
Total Cash 41,295,000
Total Cash Per Share 0.348
Total Debt 174,226,000
Total Revenue 436,968,992
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -0.31
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 1.07455
Two Hundred Day Average Change -0.62445
Two Hundred Day Average Change Percent -0.581127
Type Disp Equity
Volume 330,797
Website https://www.accuray.com
Zip 53,717-1954